ClinicalTrials.gg
RecruitingNCT07727018Updated Jul 27, 2026

Clinical Trial of "Exploradores de Sabores" to Improve Food Selectivity in ASD Kids

An interventional study of Exploradores de Sabores Parent-Mediated Nutrition Intervention and Education as Usual (EAU) in Autism Spectrum Disorder and Food Selectivity, sponsored by Universidad Autonoma de Baja California. Recruiting at 1 site in Mexico. Open to participants aged 4 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Universidad Autonoma de Baja California · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
4 Years to 11 Years
Sex
All
01

Study summary

The goal of this randomized, single-blind clinical trial is to evaluate the effectiveness of the Exploradores de Sabores parent-mediated nutrition intervention in reducing food selectivity and improving dietary variety, mealtime behaviors, nutritional status, and gastrointestinal symptoms among children aged 4 to 11 years with Autism Spectrum Disorder (ASD). The intervention consists of a standardized 15-week parent training program that combines nutrition education, behavioral feeding strategies, sensory-based approaches, and structured food exposure activities implemented by caregivers at home.

The main questions it aims to answer are:

  • Does the Exploradores de Sabores intervention improve food selectivity and dietary variety in children with Autism Spectrum Disorder compared with Education as Usual (EAU)?
  • Does the intervention improve mealtime behaviors, nutritional status, and gastrointestinal symptoms compared with Education as Usual (EAU)?

Researchers will compare participants assigned to the Exploradores de Sabores intervention with those receiving Education as Usual (EAU) to determine whether the intervention results in greater improvements in food selectivity, dietary variety, mealtime behaviors, nutritional status, and gastrointestinal symptoms.

Participants will:

  • Complete study assessments at baseline and immediately after completion of the 15-week intervention.
  • Be randomly assigned to either the Exploradores de Sabores intervention or the Education as Usual (EAU) control group.
  • If assigned to the intervention group, caregivers will participate in a standardized 15-week parent training program and implement structured home-based feeding activities using the intervention manual and educational materials.
  • If assigned to the Education as Usual (EAU) control group, caregivers will receive 15-week parent training in general recomendations that include healthy meal planning, hydration, and general guidance for promoting balanced eating habits. Children will undergo assessments of food selectivity, dietary variety, mealtime behaviors, nutritional status, and gastrointestinal symptoms at each study visit.
02

Conditions studied

  • Autism Spectrum Disorder
  • Food Selectivity

Keywords

  • Food Selectivity
  • Food Neophobia
  • Dietary Variety
  • Mealtime Behavior
  • Parent-Mediated Intervention
  • Nutrition Intervention
  • Nutritional Status
  • Autism Spectrum Disorder
  • Children
  • Gastrointestinal Symptoms
03

In context

Autism Spectrum Disorder

1,724 studies on the registry are indexed under Autism Spectrum Disorder; 500 are open to participants now.

This study's planned enrollment of 72 is above the median of 52 across 1,368 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

Universidad Autonoma de Baja California is the lead sponsor of 33 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children diagnosed with Autism Spectrum Disorder (ASD) requiring support levels 1, 2, or 3, without cognitive impairment.
  • Primary caregivers with sufficient availability to participate in and implement the intervention.
  • Children with or without mild functional gastrointestinal symptoms.
  • Children experiencing difficulties with the introduction or acceptance of new foods.
  • Children with food selectivity, as determined by AUT-EAT
  • Children with malnutrition.

Exclusion criteria

Exclusion Criteria:

  • Current use of medications known to substantially affect appetite or feeding behavior (e.g., cyproheptadine, clonidine, or other appetite-modifying medications).
  • Syndromic Autism Spectrum Disorder (ASD).
  • gastrointestinal disorders requiring active medical treatment.
  • Medical conditions that significantly affect nutritional status, growth, or feeding behavior (e.g., phenylketonuria, cystic fibrosis, inflammatory bowel disease, endocrine disorders, or eating disorders).
  • Cases in which the parent or legal guardian attending the training sessions is not the individual responsible for implementing the intervention activities with the child at home.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Exploradores de Sabores

    Children aged 4-11 years with Autism Spectrum Disorder (ASD) who present food selectivity. Their parents or primary caregivers will participate in the Exploradores de Sabores parent-mediated nutrition intervention. The intervention consists of a standardized 15-week parent training program including nutrition education, behavioral feeding strategies, sensory-based approaches, and structured home-based food exposure activities.

    Behavioral: Exploradores de Sabores Parent-Mediated Nutrition Intervention

  • Active comparator
    Education as Usual (EAU)

    Children aged 4-11 years with Autism Spectrum Disorder (ASD) and food selectivity whose parents or primary caregivers will continue receiving education and healthcare services as usual throughout the study. Participants will not receive the Exploradores de Sabores intervention but will continue receiving Education as Usual (EAU) throughout the study.

    Other: Education as Usual (EAU)

Interventions

  • BehavioralExploradores de Sabores Parent-Mediated Nutrition Intervention

    The Exploradores de Sabores intervention is a standardized, parent-mediated parent-mediated nutrition intervention designed to reduce food selectivity and improve dietary variety among children aged 4-11 years with Autism Spectrum Disorder (ASD). Parents participate in weekly group sessions led by a registered dietitian, combining nutrition education, responsive feeding strategies, sensory-based approaches, behavioral techniques, and gradual food exposure. Following each session, parents implement structured home-based activities using the intervention manual and educational materials, including repeated non-coercive food exposure, food play, sensory exploration, modeling, positive reinforcement, and mealtime environment modifications. The program consists of 15 weekly 40-minute sessions organized into an introductory session, three intervention phases, reinforcement sessions, and a final evaluation.

  • OtherEducation as Usual (EAU)

    Participants assigned to the control group receive Education as Usual (EAU), consisting of general nutrition and healthy eating recommendations routinely provided to families of children with Autism Spectrum Disorder (ASD). Educational content includes national dietary recommendations, healthy meal planning, hydration, and general guidance for promoting balanced eating habits. To control for attention and contact time, participants attend 15 weekly 40-minute sessions led by a registered dietitian following the same schedule as the experimental group. However, they do not receive the behavioral feeding strategies, sensory-based approaches, or systematic food exposure techniques that are unique to the Exploradores de Sabores intervention. Families continue receiving their usual healthcare and educational services throughout the study.

06

What researchers measure

Primary outcomes

  1. Food Variety

    Dietary variety will be assessed using the Food Variety Questionnaire developed by the Food and Agriculture Organization (FAO). The questionnaire records foods consumed from predefined food groups over a specified reference period. A dietary variety score is calculated based on the number of different food groups consumed, Scores range from 0 to 16, corresponding to the number of food groups consumed. Higher scores indicate greater dietary variety and a better dietary outcome.The questionnaire will be completed by the child's primary caregiver.

    Time frame: Baseline, mid-intervention, and immediately after completion of the 15-week intervention.

  2. Nutritional status

    Nutritional status will be assessed using the Screening Tool for the Assessment of Malnutrition in Paediatrics (STAMP). STAMP evaluates nutritional risk based on the child's clinical diagnosis, recent nutritional intake, weight and height measurements, and anthropometric indicators. Scores range from 0 to 9. A score of 0-1 indicates low nutritional risk, 2-3 indicates medium risk, and ≥4 indicates high nutritional risk. Higher scores indicate a greater risk of malnutrition and therefore a worse outcome. Higher scores indicate a greater risk of malnutrition.

    Time frame: From enrollment to the end of treatment at 15 weeks

  3. Food Neophobia

    Food neophobia will be assessed using the Food Neophobia Test Tool, a validated caregiver-reported questionnaire that measures children's reluctance to try unfamiliar foods. The instrument uses a 7 Likert-type scale ranging from "Strongly disagree" to "Strongly agree," The total score ranges from 10 to 70, obtained by summing the responses to the 10 items after reverse-scoring the appropriate items. Higher scores indicate greater food neophobia and therefore a worse outcome.

    Time frame: Baseline and immediately after completion of the 15-week intervention.

Secondary outcomes

  1. Food Selectivity

    Food selectivity will be assessed using the Autism Eating Assessment Tool (AUT-EAT). The caregiver-reported questionnaire evaluates eating difficulties across multiple domains, including food selectivity, sensory sensitivity, mealtime behaviors, eating habits, and the impact of feeding difficulties on daily functioning. The questionnaire consists of 41 items rated on a 5-point Likert scale , The questionnaire comprises six factors: food Uniformity and Rituals: 12 items, overeating: 7 items, chewing and swallowing problems: 7 items, food selectivity: 7 items, problematic mealtime behaviors: 4 items and food avoidance: 3 items Parents rate each item using a 5-point Likert scale, ranging from 0 (never) to 5 (very frequently).with total scores ranging from 41 to 205. Higher scores indicate greater eating difficulties and more severe feeding-related problems; therefore, higher scores represent a worse outcome.

    Time frame: Baseline and immediately after completion of the 15-week intervention.

  2. Gastrointestinal health

    Gastrointestinal health will be assessed using the Bristol Stool Form Scale (BSFS), a validated 7-point visual scale that classifies stool consistency from Type 1 (hard stools) to Type 7 (watery stools). The BSFS is used to evaluate bowel habits and gastrointestinal function, with changes in stool consistency indicating improvements or alterations in gastrointestinal health.

    Time frame: Baseline and immediately after completion of the 15-week intervention.

  3. Caregiver Satisfaction with the Intervention

    Caregiver satisfaction with the intervention will be assessed using the Client Satisfaction Questionnaire (CSQ-8), an 8-item validated questionnaire that measures participants satisfaction with the services received. Each item is rated on a 4-point Likert scale. The total score ranges from 8 to 32, with higher scores indicating greater satisfaction with the intervention and therefore a better outcome..

    Time frame: At the end of the intervention, week 15

07

Study locations

1 of 1 sites recruiting
  • Facultad de Medicina y Psicología, UABC
    Tijuana, Estado de Baja California 21100, Mexico
    Recruiting
08

References and documents

Publications

  • Vázquez FL, Torres Á, Otero P, Blanco V, Clifford Attkisson C. Psychometric properties of the Castilian Spanish version of the Client Satisfaction Questionnaire (CSQ-8). Curr Psychol. 2019;38(3):829-835. doi:10.1007/s12144-017-9641-2
  • Aiemjoy K, Altan E, Aragie S, Fry DM, Phan TG, Deng X, Chanyalew M, Tadesse Z, Callahan EK, Delwart E, Keenan JD. Viral species richness and composition in young children with loose or watery stool in Ethiopia. BMC Infect Dis. 2019 Jan 14;19(1):53. doi: 10.1186/s12879-019-3674-3. PubMed 30642268 ↗
  • Galpin J, Osman L, Paramore C. Sensory snack time: a school-based intervention addressing food selectivity in autistic children. Front Educ. 2018;3:77. doi:10.3389/feduc.2018.00077
  • Navarro-Gómez, N., & Trigueros-Ramos, R. (2025). Adaptación y validación española del AUT-EAT Questionnaire (AEQ). Revista de psicopatología y psicología clínica, 30(1), 49-59.
  • Osorio-Alamillo Y, Fuentes-Cummings J, Ruiz-Barranco A, Bidart-Behar P, Clark P, Melendez-Mier G, Bueno Hernandez N. [Adaptation in Spanish and validation in Mexico of the Screening Tool for the Assessment of Malnutrition in Paediatrics (STAMP]. Nutr Hosp. 2023 Apr 20;40(2):354-361. doi: 10.20960/nh.04333. Spanish. PubMed 36880722 ↗
  • Damsbo-Svendsen M, Frost MB, Olsen A. Development of novel tools to measure food neophobia in children. Appetite. 2017 Jun 1;113:255-263. doi: 10.1016/j.appet.2017.02.035. Epub 2017 Feb 24. PubMed 28242312 ↗
  • Kennedy G, Ballard T, Dop M. Guía para medir la diversidad alimentaria a nivel individual y del hogar. Rome: FAO; 2019.
  • Gray HL, Pang T, Agazzi H, Shaffer-Hudkins E, Kim E, Miltenberger RG, Waters KA, Jimenez C, Harris M, Stern M. A nutrition education intervention to improve eating behaviors of children with autism spectrum disorder: Study protocol for a pilot randomized controlled trial. Contemp Clin Trials. 2022 Aug;119:106814. doi: 10.1016/j.cct.2022.106814. Epub 2022 Jun 4. PubMed 35671902 ↗
  • Jara V, Aros C, Ibacache D. Programa nutricional para la selectividad alimentaria de niños y niñas con espectro autista. J Health Med Sci. 2024;10(1):15-22.
  • Baratas M, Hernando N, Mata MJ, Villalba L. Guía de alimentación ante los trastornos de alimentación en niños y niñas con Trastorno del Espectro Autista (TEA). Federación Autismo Madrid; 2013.
  • Cejudo CM, Losada AV. Influencia de la nutrición biológica en niños con trastorno del espectro autista residentes del Partido de San Miguel en la Provincia de Buenos Aires. Rev Neuronum. 2021;7(1).
  • Zulkifli MN, Kadar M, Hamzaid NH. Weight Status and Associated Risk Factors of Mealtime Behaviours among Children with Autism Spectrum Disorder. Children (Basel). 2022 Jun 21;9(7):927. doi: 10.3390/children9070927. PubMed 35883911 ↗
  • Meguid N, Anwar M, Zaki S, Kandeel W, Ahmed N, Tewfik I. Dietary Patterns of Children with Autism Spectrum Disorder: A Study Based in Egypt. Open Access Maced J Med Sci. 2015 Jun 15;3(2):262-7. doi: 10.3889/oamjms.2015.051. Epub 2015 May 7. PubMed 27275232 ↗
  • Kahathuduwa CN, West BD, Blume J, Dharavath N, Moustaid-Moussa N, Mastergeorge A. The risk of overweight and obesity in children with autism spectrum disorders: A systematic review and meta-analysis. Obes Rev. 2019 Dec;20(12):1667-1679. doi: 10.1111/obr.12933. Epub 2019 Oct 8. PubMed 31595678 ↗
  • Landa RJ, Reetzke R, Holingue CB, Herman D, Hess CR. Diagnostic Stability and Phenotypic Differences Among School-Age Children Diagnosed With ASD Before Age 2. Front Psychiatry. 2022 Mar 15;13:805686. doi: 10.3389/fpsyt.2022.805686. eCollection 2022. PubMed 35370852 ↗
  • Navarrete. Integración sensorial para reducir la ansiedad en trastornos del espectro autista. Inventio. 2021. doi:10.30973/inventio/2021.17.41/1
  • Morocho Fajardo KA, Sánchez Álvarez DE, Patiño Zambrano VP. Perfil epidemiológico del autismo en Latinoamérica. Salud Cienc Med. 2021;1(2):14-25.
  • Adams SN. The Unmasking of Autism in South Africa and Nigeria. Neuropsychiatr Dis Treat. 2024 May 8;20:947-955. doi: 10.2147/NDT.S461650. eCollection 2024. PubMed 38737770 ↗
  • Núñez Santiago P. Nutrición y trastornos del espectro autista. 2020.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Dec 2026, 4 months later.

Of 800 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 4 months is below that.

Counting every sponsor, half of 823 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 27, 2026
StartEst.
Aug 2026
Primary completionEst.
Dec 2026
CompletionEst.
Jul 2027
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07727018
Lead sponsor
Universidad Autonoma de Baja California
Responsible party
Connie Johanne Lopez Verdugo (Doctoral Candidate, Universidad Autonoma de Baja California) — Principal investigator
First posted
Jul 27, 2026
Start date
Aug 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jul 2027 (estimated)
Last update
Jul 27, 2026

Study contacts

Connie Johame López Verdugo, PHD. Candidate
Contact
lopez.connie@uabc.edu.mx
+526642588810
Genaro Rodriguez Uribe, PHD
study director · Universidad Autonoma de Baja California

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion